Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products.
Jupiter Wellness stock last closed at $0.64, up 2.22% from the previous day, and has decreased 24.85% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.05 percentage points. Jupiter Wellness stock is currently +17.09% from its 52-week low of $0.55, and -60.73% from its 52-week high of $1.64.
At the moment, there are 21.89M JUPW shares outstanding. The market capitalization of JUPW is $14.10M. In the last 24 hours, 494,648 JUPW shares were traded.
How to Buy Jupiter Wellness Stock
Not sure how to invest in Jupiter Wellness stock? Here's how.
Figure out where to buy Jupiter Wellness stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Jupiter Wellness stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Fund your brokerage account: Select your payment method and add your details.
Evaluate Jupiter Wellness stock: The Jupiter Wellness ticker symbol is JUPW. Is Jupiter Wellness stock a good investment? Should you buy shares of JUPW? How do JUPW's underlying business fundamentals look? Do top analysts think Jupiter Wellness is a good buy? Why has JUPW's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if JUPW is a good stock to buy).
Place your JUPW buy order: Decide if you will purchase JUPW shares at the current market price or use a limit order to buy JUPW shares at a particular price.
Keep tabs on your JUPW position: Create a watchlist to track your position in Jupiter Wellness stock.
Step 1: Figure out where to buy Jupiter Wellness stock
You will need a brokerage account to access the NASDAQ market and buy JUPW shares.
A brokerage account is an investment account that allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today.
There are more short-term assets than long-term liabilities on the JUPW balance sheet.
There are more short-term assets than short-term liabilities on the JUPW balance sheet.
Failed Financial Due Diligence Checks:
JUPW has cash burn of 7261761. It does not have enough cash and short-term investments to cover this.
JUPW has $6.47M in cash and short term investments. This is not enough to cover its annual cash burn of $7.26M.
JUPW has a relatively high debt to equity ratio of 0.41.
JUPW profit margin has gone up by 6.23 percentage points in the past year, but the company is still unprofitable.
JUPW Technical Indicators
How are JUPW Revenues/Earnings doing?
Last year, JUPW revenue was $6.84M. During the past two year, JUPW's revenue has increased by 201.16% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 50.68%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.